C.M. Bidwell & Associates’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-637
Closed -$309K 552
2023
Q1
$309K Buy
637
+5
+0.8% +$2.47K 0.23% 70
2022
Q4
$324K Buy
+632
New +$332K 0.26% 67
2020
Q4
Sell
-295
Closed -$122K 505
2020
Q3
$122K Buy
+295
New +$119K 0.11% 174
2017
Q3
Sell
-19,000
Closed -$4.57M 335
2017
Q2
$4.57M Buy
+19,000
New +$4.3M 0.98% 36
2015
Q2
Sell
-1,520
Closed -$271K 239
2015
Q1
$271K Sell
1,520
-105
-6% -$16.6K 0.06% 128
2014
Q4
$233K Sell
1,625
-10
-0.6% -$1.37K 0.05% 140
2014
Q3
$213K Buy
+1,635
New +$208K 0.05% 146

Other funds holding HUM

C.M. Bidwell & Associates's HUM Position: Q2 2023 in Review

C.M. Bidwell & Associates sold out of Humana (HUM) in Q2 2023, closing a stake of 637 shares — an estimated $309K sold.

C.M. Bidwell & Associates first reported a position in HUM in Q3 2014 and held it in 7 quarters. The position peaked at $4.57M in Q2 2017. 1,072 funds tracked by Wall St. Rank hold HUM as of Q2 2023.

  • C.M. Bidwell & Associates reported no remaining Humana position as of Q2 2023 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 637 Humana shares in Q2 2023, an estimated $309K.
  • C.M. Bidwell & Associates first reported a position in Humana in Q3 2014 and held it in 7 quarters.
  • C.M. Bidwell & Associates's Humana position peaked at $4.57M in Q2 2017.
  • 1,072 funds tracked by Wall St. Rank held Humana as of Q2 2023.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2023, filed 14 Aug 2023.